Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythrocyte-based drug delivery.

Luiga Rossi1, Sonja Serafini, Francesca Pierigé

  • 1Università degli Studi di Urbino Carlo Bo, Istituto di Chimica Biologica G Fornaini, Italy.

Expert Opinion on Drug Delivery
|November 22, 2005
PubMed
Summary

Erythrocytes, or red blood cells, serve as effective physiological carriers for drug delivery, enhancing therapeutic efficacy and minimizing side effects. This technology, utilizing autologous erythrocyte encapsulation, is clinically viable and competitive.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Red Blood Cell-Encapsulated Nanoparticles for Long-Circulating, Improved Specificity Functional MRI.

Chemical & biomedical imaging·2026
Same author

Predicting the success of an antibody: Biochemical and biophysical characterization of the humanized monoclonal antibody Dia-T51.

International journal of biological macromolecules·2026
Same author

Synthesis and Characterization of a Novel Biphenol-Based Gadolinium Complex for Encapsulation in Human Red Blood Cells.

International journal of molecular sciences·2026
Same author

Early ADME and Preliminary Toxicity Studies of I-152, an <i>N</i>-Acetyl-l-Cysteine/<i>S</i>-Acetylcysteamine Conjugate.

Chemical research in toxicology·2026
Same author

Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study.

Frontiers in immunology·2026
Same author

Candidozyma auris-infected Galleria mellonella larvae: the effect of the humanized monoclonal antibody Dia-T51 and its synergy with amphotericin B.

npj antimicrobials and resistance·2026

Area of Science:

  • Biomedical Engineering
  • Pharmacology
  • Drug Delivery Systems

Background:

  • Physiological carriers offer a promising approach to improve therapeutic efficacy and reduce adverse effects.
  • Erythrocytes (red blood cells) possess unique properties making them suitable for delivering various molecules, including proteins and therapeutic agents.
  • Targeting macrophages with carrier erythrocytes presents opportunities for treating intracellular pathogens.

Purpose of the Study:

  • To explore the potential of erythrocytes as physiological carriers for drug delivery.
  • To investigate the use of carrier erythrocytes for selective drug targeting to macrophages.
  • To highlight the clinical applicability and competitiveness of erythrocyte-based drug delivery systems.

Main Methods:

  • Extensive studies on the behavior of erythrocytes as delivery systems for diverse molecules (proteins, nucleotide analogues, glucocorticoid analogues).

Related Experiment Videos

  • Development of apparatus for encapsulating drugs into autologous erythrocytes.
  • Evaluation of erythrocyte encapsulation technology in clinical settings.

    • Main Results:

    • Erythrocytes demonstrate significant potential as carriers for various therapeutic molecules.
    • Selective drug targeting to macrophages using carrier erythrocytes is feasible.
    • The technology for encapsulating drugs into autologous erythrocytes is clinically available and competitive.

    Conclusions:

    • Erythrocytes are versatile and effective physiological carriers for drug delivery.
    • Erythrocyte-based drug delivery systems offer targeted treatment for intracellular pathogens and novel drug development opportunities.
    • The clinical availability and competitiveness of this drug delivery technology are established.